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Objectives The purpose of this study was to test the hypothesis that increased oxidative stress is associated with apoptosis
in human plaques with the haptoglobin (Hp) 2-2 genotype.
Background Intraplaque hemorrhage releases free hemoglobin (Hb). Impaired Hb clearance induces oxidative stress leading
to plaque progression. The binding of Hp to Hb attenuates iron-induced oxidative reactions.
Methods Twenty-six human aortic plaques were Hp genotyped. Hp2-2 plaques (n  13) were compared with control
(Hp1-1/2-1) (n  13). The iron grade was measured by Perl’s staining. Immunostaining was used to detect
oxidation-specific epitopes (OSEs) reflecting oxidized phospholipids and malondialdehyde-like epitopes. The per-
centages of apoptotic cells and apoptotic morphological features were quantified. DNA fragmentation and active
caspase-3 were measured by in situ end-labeling and immunohistochemistry, respectively.
Results In Hp2-2 plaques, iron content was increased (1.22  0.15 vs. 0.54  0.08; p  0.0001) along with expression
of oxidized phospholipid– (78.9  5.8 vs. 38.8  3.8; p  0.0001), and malondialdehyde-like OSEs (93.9  7.9
vs. 54.7  3.9; p  0.0001). The total percentages of apoptotic cells (11.9  0.44 vs. 3.5  0.28; p  0.0001),
nuclear fragmentation (11.8  0.50 vs. 3.3  0.26; p  0.0001), nuclear condensation (10.9  0.58 vs. 3.4 
0.20; p  0.0001), chromatin margination (14.2  0.57 vs. 6.5  0.37; p  0.0001), cytoplasmic blebs (1.6 
0.28 vs. 0.8  0.14; p  0.002), and eosinophilia (10.8  0.74 vs. 4.2  0.27; p  0.0001) were increased in
Hp2-2 plaques. Furthermore, DNA fragmentation (119.9  1.40 vs. 57.5  0.80; p  0.001), and active caspase-3
density (84.7  7.62 vs. 50.6  7.49; p  0.004) were increased in Hp2-2 plaques. Logistic regression analysis iden-
tified correlation between the percentage of apoptotic cells and the density of OSEs (r  0.56; p  0.003).
Conclusions These findings provide insights into genetic predisposition to oxidative stress and the relationship between OSEs
and macrophage apoptosis that may explain advanced atherosclerosis in human Hp2-2 plaques. (J Am Coll
Cardiol 2012;60:112–9) © 2012 by the American College of Cardiology Foundation
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July 10, 2012:112–9 Oxidation-Specific Epitopes and ApoptosisAtherosclerotic plaque progression is associated with in-
creased inflammation, neovascularization, and intraplaque
hemorrhage (1–4). Extravasation of erythrocytes into the
atherosclerotic plaque releases free hemoglobin (Hb) (5).
Impaired Hb clearance leads to increased iron deposition
and generation of reactive oxygen species. This may further
promote oxidation of lipoproteins (6). As a result, the core
of advanced atheromatous plaques is a pro-oxidant milieu,
which may promote apoptosis. This pro-oxidant activity of
free Hb is antagonized by haptoglobin (Hp) (7), a plasma
protein that binds Hb with high affinity. The heme iron in
Hb is a very potent oxidant, and the binding of Hp to Hb
attenuates the iron-induced oxidative reactions and acts as
an antioxidant by promoting clearance of Hb by the
macrophage CD163 scavenger receptor (8).
In humans, there is genetic polymorphism at the Hp
locus with 2 alleles: 1 and 2. Specifically, the protein product
of the Hp2 allele is defective in its ability to block oxidative
reactions mediated by iron derived from Hb (6). Impaired
Hb clearance and increased iron deposition observed in
Hp2-2 plaque may induce oxidative modifications of lipo-
proteins (7). A variety of oxidation-specific epitopes (OSEs)
is generated during oxidative modification of plaque lipo-
roteins (9–11). These epitopes are not only expressed on
xidized lipoproteins but also on proteins in the extracellular
atrix and apoptotic cells (12). Macrophages engulf oxi-
ized low-density lipoprotein (LDL) and oxidized lipids
nd become foam cells. This leads to increased intracellular
tress, evoking a proapoptotic phenomenon in advanced
therosclerotic lesions (13,14). Impairment in the clearance
f apoptotic cells induces secondary necrosis, which aggra-
ates plaque destabilization, resulting in atherothrombosis
15). In the present study, we quantified iron deposition,
SE, and morphological and histochemical features of
poptosis in human aortic atherosclerotic plaques stratified
y Hp genotype. Specifically, this study was designed to test
he hypothesis that human plaques from patients with the
p2-2 genotype will have increased iron content, oxidation
pitopes, and increased apoptosis compared with control
uman plaques without the Hp2-2 genotype.
ethods
issue collection. Full-thickness aortic wall histological
ections from 26 aortas were taken sequentially at autopsy
rom 26 decedents. A 20-cm aortic segment extending from
he lower thoracic aorta into the abdominal aorta above the
enal arteries was selected for examination from each case.
he aorta from each decedent was dissected, opened longi-
udinally, and grossly examined after the intima was washed
ith saline solution. Upon examination, the aortas had
iffuse atherosclerotic lesions with variably distanced spaces
etween plaques. Individual atherosclerotic plaques that
ose above the surface with a long axis 0.75 cm were
tudied (16). A 1.0-cm long  0.5-cm wide sample with an
dge of normal tissue was obtained for each plaque. All samples were obtained within
4 h of death, immediately fixed
n 10% buffered formalin, and
rocessed into paraffin blocks,
hereby decreasing the likelihood
f exposing these tissues to oxi-
ation. Only 1 plaque was ran-
omly selected without knowl-
dge of the Hp genotype and
ncluded in the study. Quantifi-
ation of apoptotic cell morphol-
gy was done by an individual
otally blinded to the genotype.
his study was approved by the
nvestigational review board at
ount Sinai Medical Center, New York, New York.
p genotype. To identify the Hp genotype, DNA was
xtracted from liver tissue of the corresponding decedents
nd amplified by polymerase chain reaction using 2 sets of
rimers specifying Hp alleles Hp1 and Hp2 (GenBank
ccession number AC004682 and M69197). Oligonucleotide
rimers A (5=-GAGGGGAGCTTGCCTTTCCATTG-3=)
nd B (5=-GAGATTTTTGAGCCCT GGCTGGT-3=) were
sed for amplification of a 1,757-bp Hp1 allele–specific
equence and primers C (5=-CCTGCCTCG TATTAACTG-
ACCAT-3=) and D (5=-CCGAGTGCTCCACATAG-
CATGT-3=) were used to amplify a 349-bp Hp2 allele–
pecific sequence. The polymerase chain reaction products
ere analyzed by agarose gel electrophoresis and the Hp
enotype identified (6).
laque characterization and iron grade. Hematoxylin and
osin–stained plaques were characterized according to the
merican Heart Association classification (16). Perl’s iron
taining was graded as follows: grade 0, absent; grade 1,
ild to moderate intensity; and grade 2, severe intensity
17,18).
uantification of OSE. Determination of the presence of
SE was performed by immunostaining using an IgM
urine monoclonal EO6 antibody, which is specific for the
hosphocholine head group of oxidized phospholipids
OxPLs), and the human Fab monoclonal IK17 antibody,
hich binds to a unique malondialdehyde (MDA) epitope
resent on both MDA-LDL and copper-oxidized LDL
19). For EO6 immunostaining, formalin-fixed paraffin
ections (5 m) were incubated overnight at 4°C with
rimary antibody (1:1,000) and detected using the LSAB2
ystem-HRP DAB kit (Dako, Carpinteria, California)
ccording to the manufacturer’s protocol. Briefly, endoge-
ous peroxidase activity was quenched by incubating the
pecimen for 5 min with 3% hydrogen peroxide. The
pecimen was then sequentially incubated with biotinylated
nti-mouse immunoglobulin, then peroxidase-labeled
treptavidin, followed by incubation with the substrate
hromogen 3,3’-diaminobenzidine resulting in a brown-
olored precipitate at the antigen site. For IK17 immuno-
Abbreviations and
Acronyms
Hb  hemoglobin
Hp  haptoglobin
LDL  low-density
lipoprotein
MDA  malondialdehyde
OSE  oxidation-specific
epitope
OxPL  oxidized
phospholipid
SMA  smooth muscle
actintaining, sections were initially incubated with nonimmune
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Oxidation-Specific Epitopes and Apoptosis July 10, 2012:112–9goat anti-human IgG (BA-3000, Vector Laboratories, Bur-
lingame, California) at 1:100 dilution in 2% goat serum to
bind to endogenous human immunoglobulins and reduce
nonspecific background staining. Then, the IK17 antibody
was diluted in 2% goat serum and incubated for 1 h at room
temperature. Bound IK17 was then visualized by incubating
with alkaline phosphatase–labeled goat anti-human -chain
secondary antibody (dilution 1:200) (A3813, Sigma Al-
drich, St. Louis, Missouri) for 1 h at room temperature
and visualized with Vector Red (SK-5100, Vector Lab-
oratories). Individual cell numbers on immunostained
slides were quantified with computerized planimetry
under a 40 objective. Dako background-reducing buffer
was used to reduce the excess background staining in the
extracellular matrix. The density of OxPLs (EO6) and
Figure 1 OSE OxPLs (EO6) and (MDA) IK17 Expression
(A and B) Immunostaining for the oxidation-specific epitope (OSE) with murine mo
expression of oxidized phospholipids (OxPLs) (EO6) in human aortic atheroscleroti
(20 magnification). (C) Bar graph showing the OxPL (EO6) density between the H
like OSEs using human IK17 Fab antibody with red chromogen labeling showing in
from the Hp2-2 genotype compared with control plaques (20 magnification). (F)
control groups.
Demographic Features ofAortic Atherosclerotic Plaque DonorsTable 1 Demog aphic Features ofAortic Atherosclerotic Plaque Donors
Hp2-2 Group
(n  13)
Control Group
(n  13) p Value
Age, yrs 65.7 3.1 67.1 3.4 0.77
Female 38 23 0.67
Diabetes mellitus 47 53 0.70
Coronary artery disease 50 50 1.00
Hypertension 43 57 0.69
Values are mean  SD or %.MDA-like (IK17) OSEs was calculated by dividing the
total number of EO6/IK17-positive cells in the plaque by
the total area (mm2) counted in 20 high-power fields and
expressed as density (i.e., number of positive cells per
square millimeter).
Percentage of apoptosis-positive cells. The total number
of apoptotic cells in plaques, including endothelium, smooth
muscle cells, and macrophages, that exhibited all the nuclear
and cytoplasmic features of apoptosis were randomly counted
by light microscopy using 20 oil-immersion high-power fields.
Morphological features of apoptosis. Five morphological
features of apoptosis were systematically recorded using hema-
toxylin and eosin staining as follows: 1) total nuclear fragmen-
tation: discontinuity in nuclear chromatin with breakage in the
nucleus, indicating DNA breakage; 2) nuclear condensation:
nuclear chromatin with dense basophilic (intense blue) stain-
ing; 3) margination of chromatin: chromatin (basophilic)
staining with peripheral margination or rimming of the chro-
matin in the nucleus; 4) cytoplasmic bleb: abnormal vacuola-
tion of the cytoplasm exhibiting protrusions or blebs (bulging);
and 5) cytoplasmic eosinophilia: dense eosinophilic (acido-
philia; pinkish color) staining of cytoplasmic content, indicat-
ing an abnormal increase in protein content.
The total percentage of apoptotic cells and all 5 morpho-
logical features of apoptosis were reported as the percentage
of the total cells counted in the entire field.
al antibody using diaminobenzene brown chromogen labeling showing increased
e derived from the haptoglobin (Hp)2-2 genotype compared with control plaques
nd control groups. (D and E) Immunostaining for the malondialdehyde (MDA)-
d expression of MDA-like OSEs in human aortic atherosclerotic plaque derived
aph representing MDA-like OSE (IK17) density between the Hp2-2 genotype andnoclon
c plaqu
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July 10, 2012:112–9 Oxidation-Specific Epitopes and ApoptosisTerminal deoxyuride-5=-triphosphate biotin nick-end
labeling assay. This assay was performed using an in situ
apoptosis detection kit (VasoTACS, Trevigen, Inc., Gaith-
ersburg, Maryland) per the manufacturer’s instructions. The
in situ end-labeling density was calculated by manually
counting the DNA fragments in 20 high-power fields and
dividing by the total area counted.
Caspase-3 assay. Immunohistochemistry for active caspase-3
expression was performed using rabbit monoclonal IgG
antibody (04-439, Millipore, Billerica, Massachusetts) with
,3=-diaminobenzidine chromogen and Elite Vectastain
it (Vector Laboratories) using an appropriate secondary
iotinylated antibody. The density of active caspase-3
as measured by manually counting the cells expressing
ctive caspase-3 in the intima of plaque in 20 high-power
elds and dividing by the total area counted in the
laque.
mmunofluorescence staining. This staining was per-
ormed using primary antibodies against the following
ntigens: active caspase-3 (ab-44976, 1:500 dilution, Ab-
Figure 2 Morphological Features of Apoptosis
Hematoxylin and eosin–stained sections showing morphological features of apopto
(upper) and cytoplasmic blebbing and eosinophilia (Eosin) (middle) under oil imm
phological features is displayed as bar graphs (lower).cam, Cambridge, Massachusetts), CD68 (M0814, 1:100
dilution, Dako), and -smooth muscle actin (SMA)
FITC- F3777, 1:500 dilution, Sigma Aldrich). Additional
ontrol slides were routinely stained in parallel by substitut-
ng the primary antibody for IgG or specific IgG isotypes
rom the same species and at the same final concentration as
he primary antibody. Secondary antibodies were donkey
nti-mouse Alexa Fluor 488 or anti-rabbit Alexa Fluor 594
A-21202 and A-21207, respectively, Invitrogen, Carlsbad,
alifornia) at 1:250 dilutions. Mounting medium contain-
ng 4,6-diamino-2-phenylindole (H-1200, Vector Labora-
ories) was then applied. Quantification of macrophages and
mooth muscle cells expressing caspase-3 was performed in
blinded fashion. Three 40 magnification fields, ran-
omly selected by the confocal Leica microscope, were
uantified. Images were acquired using Leica TCS SP5
MI, inverted confocal laser scanning microscope (Leica
icrosystems Inc., Buffalo Grove, Illinois) of Mount Sinai’s
hared Resource Facility and analyzed using the Leica LAS
F lite software system.
cluding nuclear fragmentation (Frag), margination, and condensation of chromatin
fields (100) in the haptoglobin (Hp)2-2 genotype. Quantification of these mor-sis in
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Oxidation-Specific Epitopes and Apoptosis July 10, 2012:112–9Statistical analysis. Data are presented as mean  SEM.
omparisons of means in 2 independent groups were
erformed by the 2-tailed Student t test. For nonpara-
metric data, Mann-Whitney rank sum test was used. The
categorical variables in Table 1 were compared using the
chi-square test, except for age (numerical variable), which
was compared using the 2-tailed Student t test. The
variables analyzed included OSE (EO6, IK17), apoptosis
morphology, in situ end-labeling density, and active
caspase-3 density. To evaluate correlations between ap-
optosis and OSE, linear regression analysis was used. A
p value 0.05 was used to imply statistical significance.
Statistical analyses were performed using IBM SPSS/
PASW Statistics 18 (SPSS Inc., Chicago, Illinois).
Results
Demographic data. Clinical characteristics including mean
age, sex, presence of coronary artery disease, and the
incidence of hypertension and diabetes mellitus are shown
in Table 1. No significant differences in demographic
parameters were present between groups (p  NS).
Plaque area and iron grade. Computerized planimetry
showed no difference in plaque area in the Hp2-2 aortic
plaques compared with control plaques (5.5  0.49 cm2 vs.
4.8  0.41 cm2; p  0.26). The Perl’s iron grade was
ignificantly increased in the Hp2-2 aortic plaques compared
ith control plaques (1.22 0.15 grade vs. 0.54 0.08 grade;
 0.0001).
Figure 3 DNA Fragmentation ISEL and Active Caspase-3 Expre
(A and B) Increased DNA fragmentation identified by in situ end-labeling (ISEL) (bl
compared with control plaques (40). (C) Bar graph representing ISEL density be
Hp2-2 plaques compared with control (20). (F) Bar graph depicting caspase-3 dexpression of OSEs. OxPLs and MDA-like OSEs were
ncreased in Hp2-2 plaques compared with controls (OxPLs:
8.9  5.8 vs. 38.8  3.8; p  0.0001; MDA-like OSEs:
3.9  7.9 vs. 54.7  3.9; p  0.0001) (Figs. 1A to 1F).
Morphological features of apoptosis. The total percent-
age of apoptotic cells (11.9  0.44 vs. 3.5  0.28; p 
0.0001) and all 5 morphological features of apoptosis
including total nuclear fragmentation (11.8  0.5 vs. 3.3 
0.26; p  0.0001), nuclear condensation (10.9  0.58 vs.
3.4  0.2; p  0.0001), chromatin margination (14.2  0.57
vs. 6.5 0.37; p 0.0001), cytoplasmic blebs (1.6 0.28 vs.
0.8  0.14; p  0.002), and eosinophilia (10.8  0.74 vs.
4.2  0.27; p  0.0001) were significantly increased in the
plaques derived from the Hp2-2 genotype compared with
control plaques (Fig. 2).
DNA fragmentation and active caspase-3 expression.
DNA fragmentation by the terminal deoxyuride-5=-
triphosphate biotin nick-end labeling assay was increased in
Hp2-2 plaques (119.9  1.4 vs. 57.5  0.8; p  0.001)
(Figs. 3A to 3C). Active caspase-3 was also increased in Hp
2-2 plaques when compared to controls (84.7  7.6 vs.
50.6 7.5; p0.004) (Figs. 3D to 3F). This was localized by
immunofluorescence staining, revealing frequent caspase-3 ex-
pressing CD68 macrophages in the intimal region, particu-
arly at the fibrous cap (Figs. 4A and 4B). Quantification of
acrophages expressing caspase-3 demonstrated an increase in
he number of these cells in Hp2-2 plaques versus controls
73.1  6% vs. 44.7  7%; p  0.0001). Furthermore, we
ound that caspase-3 was expressed by SMA smooth muscle
ck) in human atherosclerotic plaque from the haptoglobin (Hp)2-2 genotype
Hp2-2 and control groups. (D and E) Increased active caspase-3 expression in
between the Hp2-2 and control groups.ssion
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July 10, 2012:112–9 Oxidation-Specific Epitopes and Apoptosiscells that were localized at the fibrous cap, tunica media, and
especially in the few SMA cells within the necrotic core.
uantitation demonstrated an increase in the number of
SMA cells expressing caspase-3 in Hp2-2 plaques versus
ontrols (54.9  5% vs. 37.1  2%; p  0.001).
therwise, we identified only patchy staining for
aspase-3 in the extracellular matrix region (data not
hown). As a final analysis, binary logistic regression
dentified a direct correlation between the density of
SEs (both OxPLs and MDA-like OSEs combined) and
he percentage of apoptotic cells (r  0.56; p  0.003)
Figure 4 Macrophages and Smooth Muscle Cells Co-Localizatio
(A) Macrophages (green: CD68) exhibiting caspase-3 (red) expression. Immunofl
with merge image at 40 and the inset showing high-power view (63). Colocaliz
trols. (B) Smooth muscle cells (green: -smooth muscle actin [SMA]) exhibiting
muscle cells (green) with active caspase-3 (red) with merge image (40) and the
cells (green) and active caspase-3 (red) is seen in Hp2-2 plaques and controls. BFig. 5). discussion
his study documented increased iron deposition and ex-
ression of OSEs of plaque lipoproteins in human abdom-
nal aortic-atherosclerotic samples from patients with the
p2-2 genotype. This increased expression of OSEs was
ssociated with increased apoptosis within these Hp2-2
therosclerotic samples. Importantly, characterization of
poptosis was systematically documented by a panel of
riteria involving cell morphology and both light microscopy
nd immunohistochemistry features. This increase in oxi-
th Active Caspase-3
cence staining showing CD68 macrophages (green) and active caspase-3 (red)
f macrophages and caspase-3 is seen in haptoglobin (Hp)2-2 plaques and con-
e-3 (red) expression. Immunofluorescence staining showing SMA smooth
showing the high-power view (63). Colocalization of SMA smooth muscle
0 m.n Wi
uores
ation o
caspas
inset
ar  5ative modifications and apoptosis may help to explain
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Oxidation-Specific Epitopes and Apoptosis July 10, 2012:112–9clinical and epidemiological observations suggesting in-
creased cardiovascular events in patients with the Hp2-2
genotype (20,21).
Several groups have documented increased oxidative
stress and inflammation in plaques with intraplaque hem-
orrhage (16,22,23). The free Hb released from extravascular
erythrocytes is highly toxic due to the presence of heme iron,
a very potent oxidant. Free heme rapidly intercalates with
membranes and causes severe damage. Furthermore, heme-
derived iron participates in the Fenton reaction and in-
creases the generation of highly labile reactive oxygen free
radicals. The induction of oxidative stress catalyzes the
peroxidation of protein and lipids (6,24–26), triggering the
recruitment of inflammatory cells (macrophages and
T cells). These deleterious effects of free Hb are attenuated
by Hp, which binds with high affinity to Hb and acts as an
antioxidant by promoting clearance of Hb by the macro-
phage CD163 scavenger receptor (5).
Our finding of increased iron content in Hp2-2 plaques is
consistent with previously reported data showing that Hb-
derived iron is redox active, suggesting that plaque iron may
induce oxidative stress and lipoprotein modifications (17).
Oxidation of LDL has been implicated as a crucial factor in
the initiation and progression of atherosclerosis. In this
study, we observed increased expression of OxPLs and
MDA-like OSEs (9,10,27,28). These epitopes are gener-
ated during oxidative modification of plaque lipoproteins,
typically in proportion to plaque burden (29,30). These
epitopes are also expressed by apoptotic cells (31,32),
serving as ligands that trigger recognition and phagocytosis
by macrophages. Thus, the increased expression of OSEs in
Figure 5 Scatter Boxplot Chart Showing Relationship
Between OSEs and Percentage of Apoptotic Cells
Scatter boxplot depicting OxPLs and MDA-like OSE density (combined) in the
x-axis and percentage of apoptotic cells in the y-axis, showing a positive linear
relationship (r  0.56; p  0.003). Abbreviations as in Figure 1.Hp2-2 genotype plaques, as observed in the present study,may be due to increased oxidation of lipoproteins as well as
increased expression by apoptotic cells.
Consistent with these findings documenting a relationship
between apoptosis and OSEs, it was recently documented that
OxPLs, oxidized LDLs, saturated fatty acids, and lipopro-
tein(a), a carrier of proinflammatory OxPLs (33–35), trigger
apoptosis in endoplasmic reticulum–stressed macrophages
through a mechanism requiring both CD36 and Toll-like
receptor 2 (14). Macrophage apoptosis and necrosis are key
mechanisms in the transition of quiescent plaques to unstable
plaques. OSEs generated in the vessel wall and, in this case,
potentiated by Hp2-2 genotypes, may accelerate macrophage
apoptosis leading to plaque progression. These findings pro-
vide insights into the genetic predisposition to oxidative stress
and the relationship between OSEs and macrophage apopto-
sis, which may explain advanced atherosclerosis.
In addition, the Hp2-2 allele is a functionally inferior
protein in preventing Hb-induced oxidative stress (36) and
formation of reactive oxygen species. As an immunomodu-
lator, the Hp1-1–Hb complex stimulates macrophages to
secrete anti-inflammatory cytokines to a markedly greater
degree than the Hp2-2–Hb complex (37,38), indicating
that Hp2 is a susceptible gene for cardiovascular disease.
This may further potentiate the clinical severity in Hp2-2
individuals. Multiple independent longitudinal and cross-
sectional studies from diverse ethnic groups and geographic
areas have demonstrated that the Hp2-2 genotype is associated
with an increased risk of atherosclerotic cardiovascular disease
(39,40). As a result, the Hp genotype specifies the nature and
intensity of the macrophage response to intraplaque hemor-
rhage and thereby serves as a determinant of susceptibility to
plaque rupture and cardiovascular disease.
Study limitations. The number of cases in our study was
limited. Human atherosclerotic plaque samples were ob-
tained from post-mortem derived aorta specimen. Access to
fresh tissues for analyses such as quantitation of protein or
RNA levels was not possible. Treatment history was not
available since the source of the specimen was from the
autopsy division and many decedents had investigations/
treatments at outside hospitals.
Conclusions
Using human atherosclerotic plaque samples, we identified
that plaque iron deposition, oxidation, and apoptosis may be
genotype dependent. The further characterization of
genotype-related atherosclerosis may be instrumental in the
development of strategies for preventive measures against
cardiovascular diseases.
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